Ticker Details
Inhibrx, Inc.
IPO Date:	August 19, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.11B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.93 | 3.45%
Avg Daily Range (30 D):	$2.16 | 3.17%
Avg Daily Range (90 D):	$2.34 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.15M

Trade Size
Avg Trade Size (Sh.):	62
Avg Trade Size (Sh.) (30 D):	36
Avg Trade Size (Sh.) (90 D):	37

Institutional Trades
Total Institutional Trades:	1,392
Avg Institutional Trade:	$2.24M
Avg Institutional Trade (30 D):	$2.91M
Avg Institutional Trade (90 D):	$3.11M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.17M
Avg Closing Trade (30 D):	$2.57M
Avg Closing Trade (90 D):	$2.43M
Avg Closing Volume:	74.95K

News

Oct 24, 2025 @ 5:22 PM Stocks Soar To Records After Weak Inflation, Ford ... Source: Piero Cingari

Oct 24, 2025 @ 7:05 AM Why Are Inhibrx Biosciences Shares Soaring 76% Aft... Source: Mohd Haider

Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini

Feb 28, 2024 @ 3:25 PM Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue... Source: Zacks Equity Research

Feb 22, 2024 @ 10:15 PM BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings a... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-9.04	$-2.11	$-9.04
Diluted EPS	$-9.04	$-2.11	$-9.04
Revenue	$1.3M	$M	$1.3M
Gross Profit
Net Income / Loss	$-140.06M	$-32.83M	$-140.06M
Operating Income / Loss	$-135.03M	$-30.92M	$-135.03M
Cost of Revenue
Net Cash Flow	$-28.38M	$-28.87M	$-28.38M
PE Ratio